Tan Lee Wen, Ng Yan Er, Giok Koay Chun, Veettil Sajesh K, Menon Rohit Kunnath
School of Dentistry, International Medical University, Kuala Lumpur 57000, Malaysia.
Research Associate, Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT 81142, USA.
Antibiotics (Basel). 2023 Mar 3;12(3):512. doi: 10.3390/antibiotics12030512.
This systematic review and network meta-analysis aimed to assess the comparative efficacy and safety of antibiotics to prevent early implant failure in patients undergoing dental implant surgery.
The review was registered in PROSPERO [CRD42022319385]. A search was conducted for trials published in Medline, Cochrane, PubMed, and Scopus. A network meta-analysis was performed on the data from randomized controlled trials. Agents were ranked according to their effectiveness based on outcomes (implant failure, prosthetic failure, postsurgical complications, and adverse effects) using the surface under the cumulative ranking [SUCRA].
A total of 15 articles were included in the quantitative analysis. When compared to the placebo, 2 g of amoxicillin given 1 h preoperatively (RR = 0.42 (95%CI: 0.27, 0.67)), 2 g of amoxicillin given 1 h preoperatively with postoperative 500 mg thrice for 5 days (RR = 0.36 (95%CI: 0.15, 0.87)), and post-operative amoxicillin with clavulanic acid 625 mg 3 times daily for 5 days (RR = 0.38 (95%CI: 0.16, 0.90)) were effective in reducing early implant failures. In addition, 2 g of amoxicillin given 1 h preoperatively (RR = 0.42 (95%CI: 0.25, 0.73)) was the only protocol that was significant in the pairwise meta-analysis results. However, sensitivity analysis, which excluded trials with a high risk of bias, showed that none of the protocols were statistically significant in reducing early implant failure.
A single 2 g dose of preoperative amoxicillin significantly reduces early implant failure in healthy individuals. More high-quality trials are required to establish this recommendation, as the quality of this evidence is weak.
本系统评价和网状Meta分析旨在评估抗生素预防牙种植手术患者早期种植失败的相对疗效和安全性。
该评价已在PROSPERO[CRD42022319385]注册。对发表在Medline、Cochrane、PubMed和Scopus上的试验进行检索。对随机对照试验的数据进行网状Meta分析。根据累积排序曲线下面积(SUCRA),根据结局(种植失败、修复失败、术后并发症和不良反应)对药物的有效性进行排序。
定量分析共纳入15篇文章。与安慰剂相比,术前1小时给予2g阿莫西林(RR=0.42(95%CI:0.27,0.67))、术前1小时给予2g阿莫西林并术后500mg每日三次共5天(RR=0.36(95%CI:0.15,0.87))以及术后给予阿莫西林克拉维酸625mg每日三次共5天(RR=0.38(95%CI:0.16,0.90))在减少早期种植失败方面有效。此外,术前1小时给予2g阿莫西林(RR=0.42(95%CI:0.25,0.73))是成对Meta分析结果中唯一具有显著性的方案。然而,排除偏倚风险高的试验的敏感性分析表明,没有一个方案在减少早期种植失败方面具有统计学显著性。
单次2g剂量的术前阿莫西林可显著降低健康个体的早期种植失败率。由于该证据质量较弱,需要更多高质量试验来确立这一推荐。